| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Aug 17, 2021 | Rosenberg Noah L. Chief Medical Officer | Sell | Travere Therapeutics, Inc. | TVTX | $17.12 | $24,085 | -2.87% |
| Jul 28, 2021 | Jul 29, 2021 | Rosenberg Noah L. Chief Medical Officer | Sell | Travere Therapeutics, Inc. | TVTX | $13.81 | $17,263 | -2.73% |
| May 11, 2021 | May 13, 2021 | Rosenberg Noah L. Chief Medical Officer | Sell | Travere Therapeutics, Inc. | TVTX | $19.3 | $14,475 | -1.62% |
| Feb 05, 2021 | Feb 09, 2021 | Rosenberg Noah L. Chief Medical Officer | Sell | Travere Therapeutics, Inc. | TVTX | $31.5 | $70,864 | -4.63% |
| Feb 03, 2021 | Feb 04, 2021 | Rosenberg Noah L. Chief Medical Officer | Sell | Travere Therapeutics, Inc. | TVTX | $28.91 | $52,414 | -3.95% |
| Feb 02, 2021 | Feb 03, 2021 | Rosenberg Noah L. Chief Medical Officer | Sell | Travere Therapeutics, Inc. | TVTX | $30.75 | $55,750 | -3.80% |
| Sep 23, 2020 | Sep 24, 2020 | Rosenberg Noah L. Chief Medical Officer | Sell | Retrophin, Inc. | RTRX | $18.48 | $13,860 | -2.65% |
| Sep 22, 2020 | Sep 23, 2020 | Rosenberg Noah L. Chief Medical Officer | Sell | Retrophin, Inc. | RTRX | $18.59 | $13,943 | -2.58% |
| Jul 28, 2020 | Jul 30, 2020 | Rosenberg Noah L. Chief Medical Officer | Sell | Retrophin, Inc. | RTRX | $20.49 | $17,826 | -3.23% |
| May 12, 2020 | May 14, 2020 | Rosenberg Noah L. Chief Medical Officer | Sell | Retrophin, Inc. | RTRX | $16.98 | $8,951 | -1.93% |
| Mar 05, 2020 | Mar 10, 2020 | Rosenberg Noah L. Chief Medical Officer | Sell | Retrophin, Inc. | RTRX | $15.36 | $27,487 | -6.16% |
| Jul 30, 2019 | Aug 01, 2019 | Rosenberg Noah L. Chief Medical Officer | Sell | Retrophin, Inc. | RTRX | $19.95 | $49,863 | -15.63% |